Biden’s national and global challenges with COVID vaccinations

Last week, Americans received the reassuring news that two of the country’s largest economies, California and New York, are fully open as the COVID-19 restrictions are finally lifted.

These achievements are, of course, the result of the success of the COVID-19 vaccines manufactured by Pfizer-BioNTech, Moderna, and Johnson & Johnson. A fourth vaccine is also expected to receive FDA approval in due course after Experiments showed high vaccination effect.

Ultimately, these vaccines should be viewed and remembered as miracles of innovation. In addition, the mRNA technology used in the vaccines is has the potential Open doors to prevent other harmful viruses and conditions.

With that in mind, there are two steps to take President BidenJoe Biden 64 percent of Iowans say “time for someone else” to hold Grassley’s Senate seat: Philadelphia shooting leaves 2 dead, injuring toddler Ron Johnson, who was booed at the Wisconsin Juneteenth celebration MORE and democratic leadership next: doubling vaccination education in the United States and adjusting policies that expand vaccination to the world.

From this week, less than the half of Americans are fully vaccinated. There are also great racial differences between vaccinated and unvaccinated populations. At the time of publication, these were the Centers for Disease Control and Prevention reported this race and ethnicity was known to 57 percent of people who received at least one dose of the vaccine. Of this group, 60 percent are white, 9 percent are black, 15 percent are Hispanic, 6 percent are Asian, 1 percent are Native American or Alaskan, and less than 1 percent are Hawaiian / Pacific Islander.

Hence, Biden and the Democrats need to reverse this widespread aversion to the vaccine, especially in non-white communities. These steps are critical to achieving a 70 percent vaccination rate until independence day and thus herd immunity.

In addition to expanding vaccination education here at home, Biden and the Democratic leadership need to focus on implementing guidelines that will expand vaccination to the world – namely, protecting vaccine patents. This is a necessary step to save lives around the world and is critical to truly revitalizing our connected world and economy.

On the positive side, the government so far has shown, in some ways, that the US is committed, ready and able to be the vaccination arsenal. Biden’s announcement last week that the US will US Donate 500 million cans of COVID-19 vaccine to countries struggling with “unconditional” and “pressure for favors or potential concessions” was profound and a major mark of American vaccine leadership on the world stage.

In addition, the G7 summit in Cornwall last week and the European Union’s talks gave birth to optimistic partnerships dedicated to this goal. At the G7 summit, the heads of state and government of major industrial nations – including the USA – promised around 1 billion The COVID-19 vaccine will be given to poor countries as a “big step towards vaccinating the world,” British Prime Minister Boris Johnson said.

The only important thing that could turn this entire path to not only normalcy but also a healthy global economy on its head is to give away these life-saving vaccine formulas to inferior manufacturers in developing countries by foregoing vaccine patents.

The Announcement last month by the Biden administration give away the formulas Because our effective US-developed vaccines for developing countries, which far lack the ability to safely manufacture the billions of doses they need, is bad policy – let alone stupid and dangerous.

It is clear that the suspension of patent protection for the COVID-19 vaccine will not increase the global vaccination rate, but would actually limit the global spread of vaccines in the long term.

A select number of factories in the US even has been closed because they don’t meet the standards, and some have made spoiled doses of vaccine that they have been forced to use kick out. This is a harbinger of what could happen without the strictest production controls and patent protection.

Italy also said that they would support a waiver of vaccines. Germany and the UK against it, while the position of both Japan and Canada is unclear, although neither expressed their full support.

Pharmaceutical factories in the United States, Germany and the United Kingdom are in full swing, producing enough to provide millions of vaccine doses per day. It is absolutely vital that we duplicate this reliable and robust production and not allow low-quality vaccines to be the only option for developing countries.

Germany, which has also been a key partner in vaccination, is home to one of the most successful vaccine developers – Pfizer-BioNTech – which makes a vaccine with a high rate of effectiveness that is easy to make.

A German government spokeswoman speaks out against the suspension of patent protection argued that “the limiting factor for the manufacture of vaccines is the production capacity and the high quality standard, not the patents. The protection of intellectual property is a source of innovation and it must remain so in the future. “

Put simply, the developing world should have access to the same high quality vaccines as the American people. And make no mistake, pharmaceutical manufacturers in the major industrialized nations are the only ones who can deliver this – and ultimately the only ones who can save lives worldwide and bring the world back to normal.

Douglas E. Schoen is a political advisor to President Clinton and the 2020 presidential campaign of Michael BloombergMichael BloombergPress: Even Jeff Bezos Should Pay Income Taxes What Democrats Should Do To Achieve Real Bipartisanism 5 Former Treasury Ministers Support Biden’s Plan To Increase Tax Enforcement For The Wealthy MORE. His new book is “The End of Democracy? Russia and China on the advance and America in retreat. “

About Thelma Wilt

Check Also

Few parents intend to vaccinate very young children against Covid

Barely a month after the Food and Drug Administration approved Covid-19 vaccines for very young …

Leave a Reply

Your email address will not be published.